awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48956772-A33063AD-402B-49F2-9E5A-FFDE465E5CCF
Q48956772-A33063AD-402B-49F2-9E5A-FFDE465E5CCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48956772-A33063AD-402B-49F2-9E5A-FFDE465E5CCF
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
P2860
Q48956772-A33063AD-402B-49F2-9E5A-FFDE465E5CCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48956772-A33063AD-402B-49F2-9E5A-FFDE465E5CCF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be7c22e7fca86c83b4dafcc43f851231a1382892
P2860
Switching multiple sclerosis patients with breakthrough disease to second-line therapy.